PortfoliosLab logoPortfoliosLab logo
APLT vs. MRUS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

APLT vs. MRUS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Applied Therapeutics, Inc. (APLT) and Merus N.V. (MRUS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


APLT

1D
0.00%
1M
0.00%
YTD
3.00%
6M
-51.23%
1Y
-71.07%
3Y*
-57.59%
5Y*
-64.97%
10Y*

MRUS

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

APLT vs. MRUS - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
APLT
Applied Therapeutics, Inc.
3.00%-88.32%-74.44%340.79%-91.51%-59.34%-19.32%190.21%
MRUS
Merus N.V.
0.00%114.03%52.91%77.76%-51.35%81.40%24.50%1.37%

Correlation

The correlation between APLT and MRUS is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.18

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (All Time)
Calculated using the full available price history since May 15, 2019

0.19

Fundamentals

Market Cap

APLT:

$14.99M

MRUS:

$6.81B

EPS

APLT:

-$0.12

MRUS:

-$4.56

PS Ratio

APLT:

14.97

MRUS:

129.06

Total Revenue (TTM)

APLT:

$1.00M

MRUS:

$51.17M

Gross Profit (TTM)

APLT:

-$28.46M

MRUS:

-$111.30M

EBITDA (TTM)

APLT:

-$100.52M

MRUS:

-$323.66M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Applied Therapeutics, Inc.

Merus N.V.

Return for Risk

APLT vs. MRUS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

APLT
APLT Risk / Return Rank: 2828
Overall Rank
APLT Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
APLT Sortino Ratio Rank: 4040
Sortino Ratio Rank
APLT Omega Ratio Rank: 4646
Omega Ratio Rank
APLT Calmar Ratio Rank: 1212
Calmar Ratio Rank
APLT Martin Ratio Rank: 1919
Martin Ratio Rank

MRUS
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

APLT vs. MRUS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Applied Therapeutics, Inc. (APLT) and Merus N.V. (MRUS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


APLTMRUSDifference

Sharpe ratio

Return per unit of total volatility

-0.39

Sortino ratio

Return per unit of downside risk

0.41

Omega ratio

Gain probability vs. loss probability

1.09

Calmar ratio

Return relative to maximum drawdown

-0.77

Martin ratio

Return relative to average drawdown

-1.05

APLT vs. MRUS - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


APLTMRUSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.39

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.49

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.39

Drawdowns

APLT vs. MRUS - Drawdown Comparison


Loading charts...

Drawdown Indicators


APLTMRUSDifference

Max Drawdown

Largest peak-to-trough decline

-99.83%

Max Drawdown (1Y)

Largest decline over 1 year

-93.71%

Max Drawdown (3Y)

Largest decline over 3 years

-99.10%

Max Drawdown (5Y)

Largest decline over 5 years

-99.63%

Current Drawdown

Current decline from peak

-99.81%

Average Drawdown

Average peak-to-trough decline

-76.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

67.82%

Volatility

APLT vs. MRUS - Volatility Comparison


Loading charts...

Volatility by Period


APLTMRUSDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.00%

Volatility (6M)

Calculated over the trailing 6-month period

70.36%

Volatility (1Y)

Calculated over the trailing 1-year period

182.93%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

132.93%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

122.33%

Dividends

APLT vs. MRUS - Dividend Comparison

Neither APLT nor MRUS has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

APLT vs. MRUS - Financials Comparison

This section allows you to compare key financial metrics between Applied Therapeutics, Inc. and Merus N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M25.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJuly
1.00M
10.37M
(APLT) Total Revenue
(MRUS) Total Revenue
Values in USD except per share items

Frequently Asked Questions


APLT and MRUS have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for APLT and MRUS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer